All
I was not guilty of sexual assault; Why must the complaint be made public?
June 1st 2004Dr. Jane is a pillar of the dermatologic medical community. She has practiced in her small rural town for 10 years, is loved by her patients, and respected by her peers. She is active in community services, considers herself a religious person and has never been the recipient of any legal complaint.
Botox applications continue to expand
May 1st 2004Maui, Hawaii - Next-generation botulinum toxin treatments promise to improve problems ranging from smokers' lines to sweaty palms. However, such treatments aren't for novices - be they dermatologists or patients. "As Botox is now becoming more widely accepted and we're becoming more used to its application, we're finding new uses for it," said Kevin S. Pinski, M.D.
Study bucks trend toward narrower melanoma excisions
May 1st 2004London - J. Meirion Thomas, M.S., F.R.C.P., F.R.C.S., set out in a recent study to confirm that wide excision margin provides no advantage over narrow excision margin in melanoma. But, after studying 900 patients in the decade-long study, he found the opposite is true.
Pulsed terbinafine may be best option for some with toenail onychomycosis
May 1st 2004Washington - The therapy of choice for the treatment of toenail onychomycosis remains continuous doses of terbinafine (Lamisil), according to Erin Warshaw, M.D. In certain situations, however, pulse dosing may play a role.
Integrated analysis underlines etanercept efficacy in psoriasis
May 1st 2004Washington - Results of a multistudy analysis reinforce the efficacy of subcutaneous etanercept (Enbrel, Amgen) for inducing rapid and sustained improvement in patients with chronic plaque psoriasis, said Kenneth Gordon, M.D., at the annual meeting of the American Academy of Dermatology.
Contact dermatitis from topicalstops list of adverse drug reactions
May 1st 2004Boca Raton, Fla. - Contact dermatitis from topical medications is the most common type of adverse drug reaction, and allergic contact dermatitis is the most common and most important form of contact dermatitis induced by topical drugs, according to James S. Taylor, M.D., head of the industrial dermatology section of the department of dermatology at the Cleveland Clinic Foundation in Cleveland. "Patients with medicament contact dermatitis usually have a good prognosis, but with a propensity for relapse," he said.
Pimecrolimus cream shows better tolerability
May 1st 2004Washington - Pimecrolimus cream 1 percent showed better local tolerability than tacrolimus ointment 0.03 percent in pediatric patients with moderate atopic dermatitis, and the patients or their primary caregivers rated most of the formulation attributes of the pimecrolimus cream as being significantly better than those of the tacrolimus ointment, according to a recent Phase IV study presented at the American Academy of Dermatology annual meeting.
Oral tazarotene for psoriasis: Effective on difficult-to-treat area
May 1st 2004Washington - Oral tazarotene offers rapid and durable clinical improvement in difficult-to-treat psoriatic lesions on the elbows and knees, said Sewon Kang, M.D., at the 62nd annual meeting of the American Academy of Dermatology.
Pediatric MRSA skin abscessesmight not require antibiotics to heal
May 1st 2004Dallas - Most community-acquired methicillin-resistant staphylococcus aureus (MRSA) skin and soft tissue abscesses smaller than 5 cm can be managed with standard incision and drainage, without the need for antibiotic therapy, according to a new study.
Being charitable is considered fraudulent?
May 1st 2004Dr. Bob has a large, mostly medical, dermatology practice. The practice is divided almost equally into patients whose health care insurance is provided by managed care organizations and those whose insurance is provided by federally insured policies with either Medicare or Medicaid.